UY27185A1 - Dosificación metronómica de taxanos - Google Patents

Dosificación metronómica de taxanos

Info

Publication number
UY27185A1
UY27185A1 UY27185A UY27185A UY27185A1 UY 27185 A1 UY27185 A1 UY 27185A1 UY 27185 A UY27185 A UY 27185A UY 27185 A UY27185 A UY 27185A UY 27185 A1 UY27185 A1 UY 27185A1
Authority
UY
Uruguay
Prior art keywords
taxanos
metronomic
metronomic dosage
dosage
taxanes
Prior art date
Application number
UY27185A
Other languages
English (en)
Inventor
William C Rose
Joseph Fargnoli
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of UY27185A1 publication Critical patent/UY27185A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Carpets (AREA)

Abstract

Se proporciona un régimen de dosificación metronómica para taxanos, el cual inhibe el desarrollo tumoral en animales.
UY27185A 2001-02-28 2002-02-25 Dosificación metronómica de taxanos UY27185A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28

Publications (1)

Publication Number Publication Date
UY27185A1 true UY27185A1 (es) 2002-09-30

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27185A UY27185A1 (es) 2001-02-28 2002-02-25 Dosificación metronómica de taxanos

Country Status (31)

Country Link
EP (1) EP1372636B1 (es)
JP (1) JP2004538253A (es)
KR (1) KR20030086276A (es)
CN (1) CN1533273A (es)
AR (1) AR033609A1 (es)
AT (1) ATE331511T1 (es)
BG (1) BG108167A (es)
BR (1) BR0207519A (es)
CA (1) CA2439299A1 (es)
CY (1) CY1105468T1 (es)
CZ (1) CZ20032232A3 (es)
DE (2) DE02723255T1 (es)
DK (1) DK1372636T3 (es)
EE (1) EE200300413A (es)
ES (1) ES2211374T3 (es)
HR (1) HRP20030775A2 (es)
HU (1) HUP0402115A2 (es)
IL (1) IL157356A0 (es)
IS (1) IS6924A (es)
MX (1) MXPA03007655A (es)
NO (1) NO20033809L (es)
PE (1) PE20020955A1 (es)
PL (1) PL373376A1 (es)
PT (1) PT1372636E (es)
RU (1) RU2003129233A (es)
SK (1) SK10332003A3 (es)
TR (1) TR200400375T3 (es)
UY (1) UY27185A1 (es)
WO (1) WO2002067928A2 (es)
YU (1) YU66603A (es)
ZA (1) ZA200306450B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
JP5645340B2 (ja) * 2003-10-15 2014-12-24 メディゲーネ アクチエンゲゼルシャフトＭｅｄｉＧｅｎｅ ＡＧ 活性成分を含有するカチオンリポソームの投与方法
US9233094B2 (en) 2005-05-04 2016-01-12 Medigene Ag Method of administering a cationic liposomal preparation
RU2448697C2 (ru) 2006-03-22 2012-04-27 Медигене Аг Лечение рака молочной железы, негативного по трем рецепторам

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002500667A (ja) * 1997-05-27 2002-01-08 ベーカー ノートン ファーマシューティカルズ インコーポレイテッド 人間の患者に対して経口的にタキサン類を投薬するための方法及び組成物
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
ES2211374T3 (es) 2007-03-01
CA2439299A1 (en) 2002-09-06
TR200400375T3 (tr) 2004-04-21
YU66603A (sh) 2006-08-17
KR20030086276A (ko) 2003-11-07
HRP20030775A2 (en) 2005-02-28
ZA200306450B (en) 2004-11-19
ES2211374T1 (es) 2004-07-16
WO2002067928A2 (en) 2002-09-06
DE60212813T2 (de) 2007-01-18
RU2003129233A (ru) 2005-02-10
JP2004538253A (ja) 2004-12-24
EE200300413A (et) 2003-12-15
AR033609A1 (es) 2003-12-26
ATE331511T1 (de) 2006-07-15
BR0207519A (pt) 2005-03-08
DK1372636T3 (da) 2006-11-06
WO2002067928A3 (en) 2003-10-09
DE60212813D1 (de) 2006-08-10
CN1533273A (zh) 2004-09-29
EP1372636B1 (en) 2006-06-28
MXPA03007655A (es) 2003-12-04
IL157356A0 (en) 2004-02-19
SK10332003A3 (sk) 2005-03-04
HUP0402115A2 (hu) 2005-02-28
EP1372636A2 (en) 2004-01-02
CY1105468T1 (el) 2010-04-28
DE02723255T1 (de) 2004-07-15
PT1372636E (pt) 2006-09-29
NO20033809D0 (no) 2003-08-27
PE20020955A1 (es) 2002-10-30
IS6924A (is) 2003-08-22
NO20033809L (no) 2003-10-23
BG108167A (en) 2004-09-30
PL373376A1 (en) 2005-08-22
CZ20032232A3 (en) 2004-06-16

Similar Documents

Publication Publication Date Title
AR095848A2 (es) Derivados imidazolicos de propionamida moduladores de receptores opioides
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
DK1773885T3 (da) Humaniserede anti-c-met-antagonister
PA8637101A1 (es) Terapia para el cancer resistente al platino
CY1115713T1 (el) Παραγωγα ακρυλαμιδιου ως αντιβιοτικοι παραγοντες
ES2421516T3 (es) Composiciones para tratar el cáncer usando el inhibidor de proteasomas PS-341
UY28757A1 (es) Compuestos de pirazolina substituidos, su preparación y su uso como medicamentos
ITRM20020301A0 (it) Macchina per radioterapia intraoperatoria.
ATE438063T1 (de) Leuchte mit hauptlichtquelle und zusatzlichtquelle
CL2009000545A1 (es) Uso de un antagonista de c-met y un antagonista de her para el tratamiento de cancer.
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
BG106738A (en) A method for chemoprevention of prostate cancer
ATE458487T1 (de) Tumorbehandlung mit gliotoxin-derivaten
NI200700139A (es) Formulaciones de benzoxazoles sustituidos
CY1108226T1 (el) Αντικαρκινικες ενωσεις βασισμενες σε καχαλαλιδης f
UY28344A1 (es) Nuevos compuestos
UY27185A1 (es) Dosificación metronómica de taxanos
MA27207A1 (fr) Compositions a utilisations therapeutiques comprenant une vitamine, un sel
ATE529432T1 (de) Azazyklosteroid als ligande der histamin-3 rezeptoren
ECSP045408A (es) Composición farmacéutica que comprende arsenito para el tratamiento de malignidad
BRPI0513825A (pt) combinações de epotilona
BRPI0409175A (pt) preparação farmacêutica oral para antagonistas de bombeamento de próton
CO5601016A2 (es) Formulaciones sedantes sin benzodiazepina
ATE551999T1 (de) P-glycoprotein-hemmer mit octiloniumbromid als wirkstoff
GT200400113A (es) Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141112